Editor-in-Chief:

Mark A. Babizhayev
Innovative Vision Products, Inc.
County of New Castle, Delaware,
USA



Associate Editors:

Ryan Donnelly
School of Pharmacy
Queen's University Belfast
Belfast
UK


Brahma N. Singh
Product Development Group
Forest Research Institute, Inc.
New York 11725
USA


Regional Editors:

George Voyiatzis
Foundation for Research and Technology
Inst. of Chemical Engineering
FORTH/ICE-HT
Rio-Patras, Greece


Tsutomu Yasukawa
Department of Ophthalmology and Visual Science
Nagoya City University
Nagoya, Japan




Editorial Advisory Board:

F. Acarturk (Gazi University, Ankara, Turkey)
A. Agrawal (Dyodelta Biosciences Ltd, Cambridgeshire, UK)
F. Ahmed (Jamia Hamdard, New Delhi, India)
C. Allen (University of Toronto, Toronto, Canada)
A.I. Alvarez (University of Leon Campus Vegazana, Leon, Spain)
M. Amiji (Northeastern University, Boston, MA, USA)
B.G. Amsden (Queen's Univ., Kingston, ON, Canada)
A.G. Asuero (The University of Seville, Seville, Spain)
M.A. Babizhayev (Innovation Vision Products, Inc., New Castle, Delaware, USA)
T. Baczek (Medical University of Gdansk, Gdansk, Poland)
M.B. Bally (British Columbia Cancer Agency, Vancouver, Canada)
A.K. Banga (Mercer University, Atlanta, GA, USA)
A.K. Bansal (Nat. Inst. Pharmaceutical Edu and Res, Mohali, India)
E.H. Barash (Chief Patent Counsel, West Lafayette, IN, USA)
A.W. Basit (University of London, London, UK)
S. Benita (Hebrew University of Jerusalem, Jerusalem, Israel)
E. Bilensoy (Hacettepe University, Ankara, Turkey)
G. Bonora (Università di Trieste,Trieste, Italy)
M. Bourin (Universite de Nantes, Cedex, France)
S. Brocchini (University of London, London, UK)
M. Brunner (Medical Univ. of Vienna, Vienna, Austria)
G. Buckton (University of London, London, UK)
F.J. Burczynski (University of Manitoba, Manitoba, Canada)
N. Çelebi (Gazi University, Ankara, Turkey)
M. Cemazar (Institute of Oncology, Ljubljana, Solvenia)
H.K. Chan (University of Sydney, Sydney, Australia)
Y.E. Choonara (University of the Witwatersrand, Johannesburg, South Africa)
P. Colombo (Parco Area delle Scienze, Parma, Italy)
P.P. Constantinides (Biopharmaceutical & Drug Delivery Consulting, LLC, IL, USA)
R. Conti (Univ.of Pavia, Pavia, Italy)
T. Coviello (Universita La Sapienza, Rome, Italy)
C. Davidson (Davidson, Davidson & Kappel, LLC, New York, NY, USA)
M.G. Dodov (Institute of Pharmaceutical Technology, Skopje, Macedonia)
A.O.S. El-Kadi (Univ.of Alberta, Alberta, Canada)
M.L. Elsae (University of Miami Miller, Miami, FL, USA)
J.-Y. Fang (Chang Gung Univ., Taoyuan, Taiwan)
B. Finnin (Monash University, Parkville, Australia)
R.A. Gemeinhart (The University of Illinois, Chicago, IL, USA)
M.C. Gohel (L. M. College of Pharmacy, Ahmedabad, India)
G. Golomb (The Hebrew Univ.of Jerusalem, Jerusalem, Israel)
L. González-Mariscal (Center for Res. and Adv. Studies, México, Mexico)
K. Goracinova (University of Sts Cyril and Methodius, Skopje, Macedonia)
H. Gupta (University of Colorado, Aurora, CO, USA)
H. Harashima (Hokkaido University, Hokkaido, Japan)
P. Hiremath (Pharmaceutics International Inc., Cockeysville, MD, USA)
K.R. Jadhav (Bharati Vidyapeeths Coll.of Pharmacy, Mumbai, India)
S. Jain (Nat. Inst. Pharmaceutical Edu and Res, Mohali, India)
Y. Kost (Ben Gurion University of the Negev, Beer Sheva, Israel)
G.S. Kwon (University of Wisconsin, Madison, WI, USA)
A.G. Lacko (University of North Texas Health Science Center,Texas, TX, USA)
A. Lamprecht (Univ.of Franche-Comté, France)
B. Lebleu (CNRS, Paris, France)
B.-J. Lee (Kangwon National University, Chuncheon, Korea)
H. Lennernas (Uppsala Univ., Uppsala, Sweden)
A.A. Linninger (The University of Illinois, Chicago, IL, USA)
J. Lisziewicz (The Therapeutic Vaccine Company, Washington, WA, USA)
Y. Maitani (Hoshi University, Tokyo, Japan)
H.M. Mansour (UK College of Pharmacy, Lexington, KY, USA)
B.B. Michniak-Kohn (The State University of NJ, Piscataway, NJ, USA)
X. Ming (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)
T. Minko (The State University of New Jersey, Piscataway, NJ, USA)
P.R. Mishra (Central Drug Research Institute, Lucknow, India)
A. Misra (The Maharaja Sayajirao Univ. of Baroda, Vadodara, India)
A.K. Mitra (Univ.of Missouri-Kansas City, Kansas City, MO, USA)
S.M. Moghimi (University of Copenhagen, Copenhagen, Denmark)
A.S. Mundada (S.S.D.J. College of Pharmacy, Maharashtra, India)
M. Morishita (Hoshi Univ., Tokyo, Japan)
L. Mu (Division of Toxicology, Laurel, MD, USA)
S.N. Murthy (The Univ. of Mississippi, Oxford, MS, USA)
R.J. Neufeld (Queen’s University Kingston, Ontario, K7L 3N6, Canada)
Y. Obata (Hoshi University, Tokyo, Japan)
M. Ogris (Ludwig-Maximilians-Universitat, Munich, Germany)
A. Omri (Laurentian University,Ontario, ON, Canada)
Y. Perrie (Aston University, Birmingham, UK)
V. Pillay (University of the Witwatersrand, Johannesburg, South Africa)
D. Quintanar-Guerrero (Universidad Nacional Autónoma de México, State of Mexico, Mexico)
R.L. Remmele (Amgen Inc., CA, USA)
V.A. Saharan (Institute of Pharmaceutical Sciences and Drug Research, Rajasthan, India)
D.K. Sarker (The University of Brighton, Brighton, UK)
A.G. Schatzlein (Univ. of Glasgow, Glasgow, UK)
R.M. Schiffelers (Utrecht Inst. for Pharmaceut. Sciences, Utrecht, Netherlands)
J. Singh (North Dakota State Univ., Fargo, ND, USA)
M.K. Singh (Dabur Research Foundation, Pune, India)
M. Singh (Chiron Corporation, Emeryville, CA, USA)
P.J. Sinko (The State Univ. of New Jersey, New Jersey, NJ, USA)
A. Sintov (Ben-Gurion University of the Negev , Beer-Sheva, Israel)
G. Smaldone (State Univ. of New York at Stony Brook, New York, NY, USA)
J. Smart (University of Brighton, Brighton, UK)
E.B. Souto (Fernando Pessoa University, Porto, Portugal)
S. Srcic (Univ.of Ljubljana, Ljubljana, Slovenia)
B. Steffansen (University of Copenhagen, Copenhagen, Denmark)
S. Svenson (Dendritic NanoTechnologies Inc., Mount Pleasant, MI , USA)
S. Talegaonkar (Jamia Hamdard, New Delhi, India)
A.K. Tiwary (Punjabi University, Patiala, India)
A.G. Thombre (Pfizer Inc,Groton, CT, USA)
S. Tommasi (National Cancer Centre, Bari, Italy)
V.P. Torchilin (Northeastern Univ., Boston, MA, USA)
M.L. Torre (Univ. of Pavia, Pavia, Italy)
I. Toth (University of Queensland, Brisbane, Australia)
E. Touitou (The Hebrew University of Jerusalem, Jerusalem, Israel)
I.F. Uchegbu (Univ.of London, School of Pharmacy, UK)
N. Udupa (Manipal College of Pharmaceutical Sciences, Manipal, India)
G. van den Mooter (Katholieke Univ. Leuven, Leuven, Belgium)
S. Venkatraman (School of Materials Sci. & Eng., Singapore)
H. Viernstein (University of Vienna, Vienna, Austria)
S.P. Vyas (Dr. Harisingh Gour Univ., Sagar, India)
M. Webb (British Columbia Cancer Research Centre, Vancouver, Canada)